PEDIATRICS Vol. 78 No. 4 October 1986, pp. 748-756
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbeter, A. M.
Right arrow Articles by Plotkin, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbeter, A. M.
Right arrow Articles by Plotkin, S. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Varicella Vaccine Studies in Healthy Children and Adults

Allan M. Arbeter MD1, Stuart E. Starr MD1, and Stanley A. Plotkin MD1

1 From the Department of Pediatrics, Albert Einstein Medical Center—Northern and Temple University School of Medicine and The Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia

Immunization of normal children and adults with Oka strain live varicella vaccine from several manufacturers has been studied in our laboratory and elsewhere. This paper summarizes clinical trials designed to obtain information on minimum dose immunogenicity pre- and postexposure prophylaxis, immunization of various age groups, and booster immunizations for seropositive individuals. These studies documented a 94% to 100% seroconversion rate with 95% to 100% persistence of antibodies at 3 to 4 years. Protective efficacy was more than 90%, and the vaccine was successful in preventing varicella when a high dose was given postexposure. Clinical reactions were limited to temperature elevations and minor papulovesiculan rashes that occurred in 5% to 10% of vaccinees. Herpes zoster has been absent in vaccinated healthy individuals.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
S. L. Tillieux, W. S. Halsey, E. S. Thomas, J. J. Voycik, G. M. Sathe, and V. Vassilev
Complete DNA Sequences of Two Oka Strain Varicella-Zoster Virus Genomes
J. Virol., November 15, 2008; 82(22): 11023 - 11044.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Marin, H. C. Meissner, and J. F. Seward
Varicella Prevention in the United States: A Review of Successes and Challenges
Pediatrics, September 1, 2008; 122(3): e744 - e751.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. T. D'Angio, P. A. Boohene, A. Mowrer, S. Audet, M. A. Menegus, D. S. Schmid, and J. A. Beeler
Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants
Pediatrics, March 1, 2007; 119(3): e574 - e579.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. F. Seward, J. X. Zhang, T. J. Maupin, L. Mascola, and A. O. Jumaan
Contagiousness of Varicella in Vaccinated Cases: A Household Contact Study
JAMA, August 11, 2004; 292(6): 704 - 708.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K. Galil, B. Lee, T. Strine, C. Carraher, A. L. Baughman, M. Eaton, J. Montero, and J. Seward
Outbreak of Varicella at a Day-Care Center despite Vaccination
N. Engl. J. Med., December 12, 2002; 347(24): 1909 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
T. Wallington and E. Weir
Varicella control and vaccine coverage: issues and challenges
Can. Med. Assoc. J., March 1, 2002; 166(5): 631 - 632.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Active Immunization in the United States: Developments over the Past Decade
Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. Watson, J. Seward, A. Yang, P. Witte, J. Lutz, C. Chan, S. Orlin, and R. Levenson
Postexposure Effectiveness of Varicella Vaccine
Pediatrics, January 1, 2000; 105(1): 84 - 88.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Infectious Diseases
Varicella Vaccine Update
Pediatrics, January 1, 2000; 105(1): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. Grose
Varicella-Zoster Virus: Less Immutable Than Once Thought
Pediatrics, May 1, 1999; 103(5): 1027 - 1028.
[Full Text]

Home page
 Arch Fam MedHome page
L. L. MacFarlane, M. L. Sanders, and P. J. Carek
Concerns Regarding Universal Varicella Immunization: Time Will Tell
Arch Fam Med, November 1, 1997; 6(6): 537 - 541.
[Abstract] [PDF]

Home page
 JAMAHome page
T. A. Lieu, S. L. Cochi, S. B. Black, M. E. Halloran, H. R. Shinefield, S. J. Holmes, M. Wharton, and A. E. Washington
Cost-effectiveness of a Routine Varicella Vaccination Program for US Children
JAMA, February 2, 1994; 271(5): 375 - 381.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
J. N. Longfield, R. E. Winn, R. L. Gibson, S. V. Juchau, and P. V. Hoffman
Varicella Outbreaks in Army Recruits From Puerto Rico: Varicella Susceptibility in a Population From the Tropics
Arch Intern Med, May 1, 1990; 150(5): 970 - 973.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
S. E. STRAUS, J. M. OSTROVE, G. INCHAUSPE, J. M. FELSER, A. FREIFELD, K. D. CROEN, and M. H. SAWYER
Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention
Ann Intern Med, February 1, 1988; 108(2): 221 - 237.
[Abstract] [PDF]